1. Home
  2. XNCR vs VSEC Comparison

XNCR vs VSEC Comparison

Compare XNCR & VSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • VSEC
  • Stock Information
  • Founded
  • XNCR 1997
  • VSEC 1959
  • Country
  • XNCR United States
  • VSEC United States
  • Employees
  • XNCR N/A
  • VSEC N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • VSEC Military/Government/Technical
  • Sector
  • XNCR Health Care
  • VSEC Consumer Discretionary
  • Exchange
  • XNCR Nasdaq
  • VSEC Nasdaq
  • Market Cap
  • XNCR 547.8M
  • VSEC 3.2B
  • IPO Year
  • XNCR 2013
  • VSEC N/A
  • Fundamental
  • Price
  • XNCR $8.60
  • VSEC $164.51
  • Analyst Decision
  • XNCR Buy
  • VSEC Strong Buy
  • Analyst Count
  • XNCR 10
  • VSEC 4
  • Target Price
  • XNCR $23.33
  • VSEC $145.00
  • AVG Volume (30 Days)
  • XNCR 734.4K
  • VSEC 206.6K
  • Earning Date
  • XNCR 11-05-2025
  • VSEC 11-04-2025
  • Dividend Yield
  • XNCR N/A
  • VSEC 0.24%
  • EPS Growth
  • XNCR N/A
  • VSEC 31.62
  • EPS
  • XNCR N/A
  • VSEC 0.95
  • Revenue
  • XNCR $146,929,000.00
  • VSEC $1,253,105,000.00
  • Revenue This Year
  • XNCR $22.06
  • VSEC $2.95
  • Revenue Next Year
  • XNCR N/A
  • VSEC $14.66
  • P/E Ratio
  • XNCR N/A
  • VSEC $51.64
  • Revenue Growth
  • XNCR N/A
  • VSEC 52.47
  • 52 Week Low
  • XNCR $6.92
  • VSEC $80.61
  • 52 Week High
  • XNCR $27.24
  • VSEC $169.78
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 57.89
  • VSEC 55.70
  • Support Level
  • XNCR $8.25
  • VSEC $160.00
  • Resistance Level
  • XNCR $8.73
  • VSEC $169.63
  • Average True Range (ATR)
  • XNCR 0.38
  • VSEC 4.55
  • MACD
  • XNCR 0.07
  • VSEC -0.79
  • Stochastic Oscillator
  • XNCR 78.76
  • VSEC 54.45

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About VSEC VSE Corporation

VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.

Share on Social Networks: